Shanghai Lee kai Technology Co.,ltd
励楷科技
Shanghai Lee kai Technology Co.,ltd
Other
Lisheng Technology completed nearly RMB 500 million in Series D financing, which will be invested in R&D, capacity building, and international expansion to strengthen its advantages in the neurointerventional device field.
Latest round: Strategic (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-09-11
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.